John Minardo 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Feb 25, 2026
Insider Transaction Report
Form 4
John Minardo
Chief Legal Officer
Transactions
- Sale
Class A Common Stock
[F1][F2]2026-02-23$3.81/sh−17,439$66,443→ 382,939 total - Sale
Class A Common Stock
[F1][F3]2026-02-24$3.66/sh−19,053$69,734→ 363,886 total
Footnotes (3)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Signature
/s/ Amir Vitale, Attorney-in-Fact|2026-02-25